Anti-CCR4/CD194 Antibody (Mogamulizumab)
Catalog No.
F1116
Anti-CCR4/CD194 Antibody (Mogamulizumab)
Featured Products
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells through antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancer, adult T-cell leukemia/lymphoma (ATLL), and cutaneous T-cell lymphoma (CTCL).
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1159266-37-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Poteligeo, KW-0761
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P51679
Human, Mouse
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CCR4 / CD194
Please avoid freeze-thaw cycles.